Brief: China Biotech Services Posts Qtrly Profit Attributable Of HK$91.3 Million
14/11/2022 14:49
Nov 14 (Reuters) - China Biotech Services Holdings Ltd
8037.HK :
* QTRLY PROFIT ATTRIBUTABLE HK$91.3 MILLION VERSUS HK$3.0
MILLION
* QTRLY TURNOVER HK$588.8 MILLION VERSUS HK$131.2 MILLION
Source text for Eikon: ID:nHKS4F73hC
Further company coverage: 8037.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on China Biotech Services Holdings
See all newsBrief: China Biotech Services Enters Cooperation Agreement
Brief: China Biotech Services Says HY Revenue From Cont Ops Hk$37.23 Million
Brief: China Biotech Services Expects HY Net Profit Of Not Less Than HK$15.0 MLN
Brief: China Biotech Services Enters Master Collaboration Agreement With Stella Pharma
Brief: China Biotech Services Says BGI Songhe Advances RMB30 Million Loan To Pengbo (Hainan)